Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 6, 2009

View Archived Issues

New Aurora B kinase inhibitors reported in recent Boehringer Ingelheim patent

New mGluR1 and mGluR5 receptor ligands discovered at Gedeon Richter

AstraZeneca identifies novel CRTh2 receptor ligands for respiratory disorders

Novel selective AT2 receptor agonists disclosed by Mitsubishi Tanabe

NVP-BEZ-235 a candidate for ovarian cancer treatment

Novel PDF inhibitors prepared and tested at Il-Dong

Novartis presents fourth quarter highlights

Phase II results for temozolomide in non-small cell lung cancer reported

Toxicity seen with everolimus/tacrolimus regimen in stem cell transplant patients

Prolonged dosing of TLR-7 agonist 852A assessed in cancer patients

Transition Therapeutics completes patient enrollment of phase II TT-223 study

Cytopia successfully concludes phase I oral CYT-997 trial

Raptor completes enrollment in phase IIa nonalcoholic steatohepatitis trial

Adventrx completes enrollment in ANX-514 bioequivalence study

BioDelivery Sciences presents initial phase I Bioral amphotericin B results

King offers new dosage strengths of Avinza for chronic pain

Trial aimed at regenerating insulin-producing capacity gets FDA approval

Oncolys initiates French phase Ib clinical study of Festinavir in HIV patients

Favrille changes name to MMR Information Systems

Oncolytics and the CTRC at UTHSCSA enter collaboration for phase II studies of Reolysin

GlaxoSmithKline and Genmab seek E.U. marketing authorization for Arzerra

Dyax expands antibody discovery collaboration with Biogen

Immunomedics' hPAM4 labeled with yttrium-90 receives fast track designation

Partnership aims to develop proof-of-concept vaccine against Chikungunya virus

UCB meets with FDA to define Cimzia regulatory path in rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...